Short Cognitive Performance Test (SKT) – Dementia Screening
The Short Cognitive Performance Test (SKT) is a neuropsychological assessment tool used to evaluate memory and attention deficits, commonly applied in the diagnosis and monitoring of dementia.
Things worth knowing about "Short Cognitive Performance Test"
The Short Cognitive Performance Test (SKT) is a neuropsychological assessment tool used to evaluate memory and attention deficits, commonly applied in the diagnosis and monitoring of dementia.
What is the Short Cognitive Performance Test?
The Short Cognitive Performance Test (German: Syndrom-Kurz-Test, abbreviated SKT) is a standardized neuropsychological test designed to assess cognitive performance, particularly in the domains of memory and attention. It is widely used for the early detection and ongoing monitoring of dementia, including Alzheimer disease. The test was originally developed by Erzigkeit in 1977 and has since been revised and standardized multiple times.
Structure and Administration
The SKT consists of nine subtests, each of which is time-limited. The total administration time is approximately 10 to 15 minutes, making it highly practical for routine clinical use. The subtests assess a range of cognitive functions through tasks involving symbols, numbers, and objects.
- Naming of objects and symbols
- Reading of numbers and symbols
- Arranging objects according to a given pattern
- Short-term and long-term memory (recognition and free recall)
- Concentration and sustained attention
Each subtest is timed, and both the time taken and the number of errors contribute to the overall score. The resulting SKT total score provides an estimate of the individual cognitive performance level.
Areas of Application
The SKT is primarily used in the following clinical and research contexts:
- Early detection of dementia and mild cognitive impairment (MCI)
- Monitoring disease progression in patients already diagnosed with dementia
- Evaluation of treatment effects in clinical trials of anti-dementia medications
- Neuropsychological baseline assessments in memory clinics and geriatric care settings
Scoring and Interpretation
The SKT is scored using age- and education-adjusted normative tables. The total score is assigned to one of five severity categories:
- Category 0: No impairment – within normal range
- Category 1: Mild impairment – borderline result
- Category 2: Moderate impairment – indicative of early cognitive decline
- Category 3: Moderately severe impairment
- Category 4: Severe impairment – significant cognitive deficits
An elevated SKT score indicates cognitive deficits and should always be interpreted in the broader clinical context. The SKT does not replace a full neuropsychological evaluation but provides valuable information for further diagnostic workup.
Advantages and Limitations
Advantages
- Brief administration time (approximately 10–15 minutes)
- Low burden on the patient and easy to administer
- Well-validated and widely used in clinical research
- Sensitive to changes over the course of illness
- Available in several parallel versions, reducing practice effects in repeated assessments
Limitations
- Cannot be used as a standalone diagnostic tool for dementia
- Results may be influenced by educational background, language proficiency, and test conditions
- Limited validity in patients with severe cognitive impairment
Comparison with Other Tests
The SKT is often used alongside other cognitive screening tools such as the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA). While the MMSE covers a broader range of cognitive domains, the SKT places a stronger emphasis on time-based performance measurement and is particularly suitable for longitudinal monitoring of cognitive change.
References
- Erzigkeit, H. (1977). SKT – Ein Kurztest zur Erfassung von Gedächtnis- und Aufmerksamkeitsstörungen. Geromed GmbH, Erlangen. Updated versions available.
- Lehfeld, H. & Erzigkeit, H. (1997). The SKT – a short cognitive performance test for assessing deficits of memory and attention. International Psychogeriatrics, 9(S1), 115–121.
- World Health Organization (WHO). (2021). Global Status Report on the Public Health Response to Dementia. Geneva: WHO Press.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryLactate tolerance test
Immune cell cloning
Vascular wall thickening
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Short Cognitive Performance Test-en